OG2023SC / Novo Nordisk  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
OG2023SC / Novo Nordisk
NCT03617081: First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.

Completed
1
40
US
NNC0113-2023, Placebo (NNC0113-2023)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
12/18
12/18

Download Options